Skip to main content
Erschienen in: Reactions Weekly 1/2012

01.09.2012 | Case report

Bevacizumab

White dot syndrome-like disease (first report) and serous retinal detachment: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Satoh S, Miyagawa Y, Mori T.Patient with recurrent central serous chorioretinopathy who developed multiple evanescent white dots and serous retinal detachment immediately following bevacizumab administration. Nippon Ganka Gakkai Zasshi 116: 119-128, No. 2, Feb 2012 - Japan Satoh S, Miyagawa Y, Mori T.Patient with recurrent central serous chorioretinopathy who developed multiple evanescent white dots and serous retinal detachment immediately following bevacizumab administration. Nippon Ganka Gakkai Zasshi 116: 119-128, No. 2, Feb 2012 - Japan
Metadaten
Titel
Bevacizumab
White dot syndrome-like disease (first report) and serous retinal detachment: case report
Publikationsdatum
01.09.2012
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2012
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214200-00047

Weitere Artikel der Ausgabe 1/2012

Reactions Weekly 1/2012 Zur Ausgabe

Case report

Diclofenac

Case report

Crizotinib